The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
出版年份 2021 全文链接
标题
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
作者
关键词
-
出版物
Scientific Reports
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-26
DOI
10.1038/s41598-021-90551-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
- (2021) Hany M. Dabbous et al. Scientific Reports
- Keep up with the latest coronavirus research
- (2020) Qingyu Chen et al. NATURE
- Features and Limitations of LitCovid Hub for Quick Access to Literature About COVID-19
- (2020) Morteza Arab-Zozani et al. Balkan Medical Journal
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis
- (2020) Wei Liu et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
- (2020) Andrey A Ivashchenko et al. CLINICAL INFECTIOUS DISEASES
- Repurposing current therapeutic regimens against SARS-CoV-2 (Review)
- (2020) Sofia Konstantinidou et al. Experimental and Therapeutic Medicine
- Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials
- (2020) Morteza Arab-Zozani et al. BMJ Open
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
- (2020) Denis Malvy et al. PLoS Neglected Tropical Diseases
- A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
- (2020) Yohei Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
- (2020) Hong Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Efficacy of various treatment modalities for nCOV‐2019: A systematic review and meta‐analysis
- (2020) Shubham Misra et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
- (2020) Yan Lou et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A systematic review of trial registry entries for randomized clinical trials investigating COVID-19 medical prevention and treatment
- (2020) Anders Peder Højer Karlsen et al. PLoS One
- Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis
- (2020) Dhan Bahadur Shrestha et al. Virology Journal
- Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia
- (2020) Faryal Khamis et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients
- (2020) Ping-Jen Chen et al. JOURNAL OF INFECTION
- FDA Approval of Remdesivir — A Step in the Right Direction
- (2020) Daniel Rubin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
- (2020) Zarir F. Udwadia et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Comparison of artificial neural network and logistic regression models for prediction of outcomes in trauma patients: A systematic review and meta-analysis
- (2019) Soheil Hassanipour et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Medical overuse in the Iranian healthcare system: a systematic review protocol
- (2018) Morteza Arab-Zozani et al. BMJ Open
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started